Historical daily share price chart and data for Dr Reddy's Laboratories since 2001 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Dr Reddy's Laboratories as of September 25, 2018 is 35.47.
| Dr Reddy's Laboratories Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2018 |
33.0678 |
37.7583 |
39.1957 |
28.2419 |
35.4700 |
-4.73% |
| 2017 |
38.4308 |
44.7075 |
45.9472 |
29.8478 |
37.2329 |
-16.42% |
| 2016 |
45.3363 |
44.6660 |
53.3952 |
40.3315 |
44.5501 |
-1.64% |
| 2015 |
54.9614 |
48.7679 |
66.3288 |
42.6113 |
45.2922 |
-7.75% |
| 2014 |
44.9451 |
38.9658 |
56.8261 |
37.3897 |
49.0988 |
23.76% |
| 2013 |
35.3684 |
32.8266 |
39.8263 |
30.7527 |
39.6716 |
24.12% |
| 2012 |
30.3414 |
28.7162 |
33.3926 |
26.1065 |
31.9625 |
14.03% |
| 2011 |
31.8363 |
34.6510 |
36.4239 |
27.6875 |
28.0304 |
-18.30% |
| 2010 |
28.4355 |
22.9165 |
38.7630 |
21.4981 |
34.3075 |
53.85% |
| 2009 |
14.1316 |
9.3318 |
24.0679 |
6.7726 |
22.2994 |
148.96% |
| 2008 |
12.1047 |
16.6010 |
16.6010 |
6.8823 |
8.9571 |
-45.69% |
| 2007 |
14.7830 |
16.3467 |
16.7802 |
13.1044 |
16.4921 |
0.34% |
| 2006 |
13.7682 |
9.8064 |
17.1477 |
9.8064 |
16.4370 |
69.17% |
| 2005 |
8.1286 |
8.8134 |
9.8289 |
6.7576 |
9.7164 |
9.63% |
| 2004 |
9.1009 |
14.3011 |
14.6609 |
6.7397 |
8.8626 |
-36.95% |
| 2003 |
10.1112 |
8.6911 |
14.2745 |
7.8246 |
14.0568 |
64.50% |
| 2002 |
8.4380 |
8.4640 |
10.4918 |
6.0829 |
8.5452 |
2.29% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$5.816B |
$2.204B |
|
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
|
